Antipsychotic use in pregnancy

Bibliography

• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2163-96
   PubMed Web of Science ®Google Scholar
• Howard LM, Kumar R, Thornicroft G. Psychosocial characteristics and needs of mothers with psychotic disorders. Br J Psychiatry 2001;178:427-32
   PubMed Web of Science ®Google Scholar
• McGrath JJ, Hearle J, Jenner L, et al. The fertility and fecundity of patients with psychoses. Acta Psychiatr Scand 1999;99(6):441-6
   PubMed Web of Science ®Google Scholar
• Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007;164(12):1817-24
   PubMed Web of Science ®Google Scholar
• Howard L, Goss C, Leese M. More than half the women with a history of psychosis have a psychiatric episode in the first year after childbirth. Schizophr Res 2004;71:49-60
   PubMed Web of Science ®Google Scholar
• Howard LM, Thornicroft G, Salmon M, et al. Predictors of parenting outcome in women with psychotic disorders discharged from mother and baby units. Acta Psychiatr Scand 2004;110(5):347-55
   PubMed Web of Science ®Google Scholar
• Kulkarni J, McCauley-Elsom K, Marston N, et al. Preliminary findings from the national register of antipsychotic medication in pregnancy. Aust N Z J Psychiatry 2008;42(1):38-44
   PubMed Web of Science ®Google Scholar
• Gilbert H. ‘About Helen’, Antipsychotic medication use during pregnancy. A case study. Aust Nurs J 2009;16(7):20
   PubMedGoogle Scholar
• Olfson M, Blanco C, Liu SM, et al. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 2012;69(12):1247-56
   PubMed Web of Science ®Google Scholar
• Alexander GC, Gallagher SA, Mascola A, et al. Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf 2011;20(2):177-84
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Duncan GE, Marx CE, et al. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005;10(1):79-104
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Inglis RJ. Road testing the newer antipsychotic agents. Aust Fam Physician 2006;35(3):96-9
   PubMedGoogle Scholar
• Markham JA, Koenig JI. Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl) 2011;214(1):89-106
   PubMedGoogle Scholar
• Satyanarayana VA, Lukose A, Srinivasan K. Maternal mental health in pregnancy and child behavior. Indian J Psychiatry 2011;53(4):351-61
   PubMedGoogle Scholar
• Davis EP, Sandman CA. Prenatal psychobiological predictors of anxiety risk in preadolescent children. Psychoneuroendocrinology 2012;37(8):1224-33
   PubMed Web of Science ®Google Scholar
• Jones I, Chandra PS, Dazzan P, et al. Bipolar disorder, affective psychosis and schizophrenia in pregnancy and the post-partum period. Lancet 2014;384(9956):1789-99
   PubMed Web of Science ®Google Scholar
• Bergink V, Bouvy PF, Vervoort JS, et al. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry 2012;169(6):609-15
   PubMed Web of Science ®Google Scholar
• Di Florio A, Forty L, Gordon-Smith K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 2013;70(2):168-75
   PubMedGoogle Scholar
• Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003;44(3):234-46
   PubMed Web of Science ®Google Scholar
• Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157(6):924-30
   PubMed Web of Science ®Google Scholar
• Bergink V, Burgerhout KM, Weigelt K, et al. Immune system dysregulation in first-onset postpartum psychosis. Biol Psychiatry 2013;73(10):1000-7
   PubMedGoogle Scholar
• Weigelt K, Bergink V, Burgerhout KM, et al. Down-regulation of infl ammation-protective microRNAs 146a and 212 in monocytes of patients with postpartum psychosis. Brain Behav Immun 2013;29:147-55
   PubMed Web of Science ®Google Scholar
• Sharma V, Smith A, Khan M. The relationship between duration of labour, time of delivery, and puerperal psychosis. J Affect Disord 2004;83(2-3):215-20
   PubMed Web of Science ®Google Scholar
• Bilszta JL, Meyer D, Buist AE. Bipolar affective disorder in the postnatal period: investigating the role of sleep. Bipolar Disord 2010;12(5):568-78
   PubMedGoogle Scholar
• Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confi dential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl 1):1-203
   PubMed Web of Science ®Google Scholar
• Austin MP, Kildea S, Sullivan E. Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Medical Journal of Australia 2007;186(7):364-7
   PubMed Web of Science ®Google Scholar
• Spinelli MG. Maternal infanticide associated with mental illness: prevention and the promise of saved lives. Am J Psychiatry 2004;161(9):1548-57
   PubMedGoogle Scholar
• Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004;161(8):1324-33
   PubMed Web of Science ®Google Scholar
• Lieberman J, Tasman A. Handbook of psychiatric drugs. John Wiley and Sons Chichester, UK; 2006. p-3
   Google Scholar
• Anderson G. Pregnancy-indurced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005;44:989-1008
   PubMed Web of Science ®Google Scholar
• Little B. Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 1999;93:858-68
   PubMed Web of Science ®Google Scholar
• Frederiksen M. Physiologic changes in pregnancy and their effect on drug disposition. Semin Perinatol 2001;25:120-3
   PubMed Web of Science ®Google Scholar
• Reis M, Kallen B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28(3):279-88
   PubMed Web of Science ®Google Scholar
• Iqbal MM, Aneja A, Rahman A, et al. The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation. Psychiatry (Edgmont) 2005;2(8):36-44
   PubMedGoogle Scholar
• Newport DJ, Calamaras MR, DeVane CL, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007;164(8):1214-20
   PubMed Web of Science ®Google Scholar
• Kostaras X, Sivertz K. The use of psychotropic medications in pregnancy and lactation. B C Med J 2005;47(3):135-8
   Google Scholar
• Raha S, Taylor VH, Holloway AC. Effect of atypical antipsychotics on fetal growth: is the placenta involved? J Pregnancy 2012;2012:315203
   PubMedGoogle Scholar
• Webb RT, Howard L, Abel KM. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev 2004(2):CD004411
   Google Scholar
• Nielsen RE. Treatment of psychosis during pregnancy – a case report and a mini-review. Acta Neuropsychiatr 2011;23(5):210-14
   PubMed Web of Science ®Google Scholar
• Newham JJ, Thomas SH, MacRitchie K, et al. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. British J Psychiatry 2008;192(5):333-7
   PubMed Web of Science ®Google Scholar
• Galbally M, Snellen M, Power J. Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Therapeutic Advances in Drug Safety 2014;5(2):100-9
   PubMedGoogle Scholar
• Murphy KC, Owen MJ. Minor physical anomalies and their relationship to the aetiology of schizophrenia. Br J Psychiatry 1996;168139-42
   Google Scholar
• Bennedsen BE, Mortensen PB, Olesen AV, et al. Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch Gen Psychiatry 2001;58(7):674-9
   PubMed Web of Science ®Google Scholar
• Abel KM. Fetal antipsychotic exposure in a changing landscape: seeing the future. Br J Psychiatry 2013;202(5):321-3
   PubMed Web of Science ®Google Scholar
• McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J. Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs 2010;17(2):97-104
   PubMedGoogle Scholar
• Koren G, Cohn T, Chitayat D, et al. Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry 2002;159(1):136-7
   PubMed Web of Science ®Google Scholar
• Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009;15(3):183-92
   PubMed Web of Science ®Google Scholar
• McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005;66(4):444-9; quiz 546
   PubMed Web of Science ®Google Scholar
• Sadowski A, Todorow M, Yazdani Brojeni P, et al. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ open 2013;3:7
   PubMed Web of Science ®Google Scholar
• Habermann F, Fritzsche J, Fuhlbruck F, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013;33(4):453-62
   PubMed Web of Science ®Google Scholar
• Friedman SH, Rosenthal MB. Treatment of perinatal delusional disorder: a case report. Int J Psychiatry Med 2003;33(4):391-4
   PubMedGoogle Scholar
• Mendhekar DN, War L, Sharma JB, et al. Olanzapine and pregnancy. Pharmacopsychiatry 2002;35(3):122-3
   PubMedGoogle Scholar
• Littrell KH, Johnson CG, Peabody CD, et al. Antipsychotics during pregnancy. Am J Psychiatry 2000;157(8):1342
   PubMedGoogle Scholar
• Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 2010;36(3):518-44
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000;20(4):399-403
   PubMed Web of Science ®Google Scholar
• Jablensky AV, Morgan V, Zubrick SR, et al. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005;162(1):79-91
   PubMed Web of Science ®Google Scholar
• Lin HC, Chen IJ, Chen YH, et al. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010;116(1):55-60
   PubMed Web of Science ®Google Scholar
• Ellman LM, Huttunen M, Lonnqvist J, et al. The effects of genetic liability for schizophrenia and maternal smoking during pregnancy on obstetric complications. Schizophr Res 2007;93(1-3):229-36
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (2011) Drug Safety Communication. Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. US Food and Drug Administration; Silver Spring, MD: 2011
   Google Scholar
• Boden R, Lundgren M, Brandt L, et al. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 2012;69(7):715-21
   PubMed Web of Science ®Google Scholar
• Johnson KC, LaPrairie JL, Brennan PA, et al. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 2012;69(8):787-94
   PubMedGoogle Scholar
• Peng M, Gao K, Ding Y, et al. Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl) 2013;228(4):577-84
   PubMed Web of Science ®Google Scholar
• Gentile S. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety 2010;27(7):675-86
   PubMed Web of Science ®Google Scholar
• Boden R, Lundgren M, Brandt L, et al. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects antipsychotics during pregnancy. Arch Gen Psychiatry 2012;69(7):715-21
   PubMed Web of Science ®Google Scholar
• Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-6
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Worsley R, Gilbert H, et al. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS One 2014;9(5):e94788
   PubMed Web of Science ®Google Scholar
• Wachs TD, Black MM, Engle PL. Maternal depression: a global threat to children’s health, development, and behavior and to human rights. Child Dev Perspect 2009;3(1):51-9
   Web of Science ®Google Scholar
• Li Z, Zeki R, Hilder L, et al. Australia’s mothers and babies 2010. Perinatal statistics series no. 27. Cat. no. PER 57. AIHW National Perinatal Epidemiology and Statistics Unit; Canberra: 2012
   Google Scholar
• Abeywardana S, Sullivan E. Congenital anomalies in Australia 2002- 2003. AIHW National Perinatal Statistics Unit; 2008
   Google Scholar
• Vissers ELM, van Ravenswaaij CMA, admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004. 36(9):955-7
   Google Scholar
• Eadie MJ. Treating Epilepsy in pregnant women. Expert Opin Pharmacother 2014;15(6):841-50
   PubMed Web of Science ®Google Scholar
• Kulkarni J. Women’s Mental Health: Antipsychotics in pregnancy. Mindcafe [online journal] 2014.(2):3-4. Available from: www.mindcafe.com.au
   Google Scholar